Our results clearly showed that a lower EPA/AA ratio, mainly observed in Groups 4–5 (Fig. 1A), was associated with a higher concentration of IL-6 and CRP, typically elevated in critically ill COVID-19 patients4,6,29,30, bringing a worse prognostic to these patients. This evidence concerns the gene IL6 and COVID-19.